Anteris Technologies Announces Presentation of First-In-Human Data for its Novel TAVR Product, DurAVR™ at the 2022 Annual TCT Congress in Boston
Investor Conference Call and KOL Forum From TCT 2022 Discussing DurAVR™Clinical Data to be Hosted on Sept 19, 2022 at...



















